{
    "id": 4005,
    "name": "endometrial transitional cell carcinoma",
    "source": "DOID",
    "definition": "An endometrial carcinoma that derives_from transitional epithelial cells. [url:http\\://en.wikipedia.org/wiki/Transitional_cell_carcinoma]",
    "currentPreferredTerm": null,
    "lastUpdateDateFromDO": "03/24/2020",
    "altIds": [
        
    ],
    "termId": "DOID:4005",
    "evidence": [
        
    ],
    "clinicalTrials": [
        {
            "nctId": "NCT02178722",
            "title": "A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of Pembrolizumab (MK-3475) in Combination With Epacadostat (INCB024360) in Subjects With Selected Cancers (INCB 24360-202 / MK-3475-037 / KEYNOTE-037/ ECHO-202)",
            "phase": "Phase Ib/II",
            "recruitment": "Active, not recruiting",
            "therapies": [
                {
                    "id": 4088,
                    "therapyName": "Epacadostat + Pembrolizumab",
                    "synonyms": null
                }
            ]
        },
        {
            "nctId": "NCT03694262",
            "title": "The EndoBARR Trial (Endometrial Bevacizumab, Atezolizumab, Rucaparib) (EndoBARR)",
            "phase": "Phase II",
            "recruitment": "Recruiting",
            "therapies": [
                {
                    "id": 7499,
                    "therapyName": "Atezolizumab + Bevacizumab + Rucaparib",
                    "synonyms": null
                }
            ]
        }
    ]
}